The Rho-kinase pathway regulates angiotensin II-induced renal damage

Kidney International

Volumn 68, Issue SUPPL. 99, 2005, Pages

  Rupérez, Mónica ^a   Sánchez López, Elsa ^a   Blanco Colio, Luis Miguel ^a   Esteban, Vanesa ^a   Rodríguez Vita, Juan ^a   Plaza, Juan José ^a   Egido, JesúS ^a   Ruiz Ortega, Marta ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Angiotensin II; Kidney; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CONNECTIVE TISSUE GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RHO KINASE; TUMOR NECROSIS FACTOR ALPHA; AMIDE; ANGIOTENSIN 1 RECEPTOR; ENZYME INHIBITOR; IMMEDIATE EARLY PROTEIN; PROTEIN SERINE THREONINE KINASE; PYRIDINE DERIVATIVE; RHO FACTOR; RHO-ASSOCIATED KINASE; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; UPREGULATION; WISTAR RAT;

AMIDES; ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CHEMOKINE CCL2; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY DISEASES; NF-KAPPA B; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RHO FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 30344447912     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.09908.x     Document Type: Conference Paper

References (39)

1. RUIZ-ORTEGA M, LORENZO O, SUZUKI Y, et al: Proinflammatory actions of Angiotensin II. Curr Opin Nephrol Hypertens 10:321-329, 2001
2. MEZZANO SA, RUIZ-ORTEGA M, EGIDO J: Angiotensin II and renal fibrosis. Hypertension 38:635-638, 2001
3. ANDERSEN S, TARNOW L, ROSSING P, et al: Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 57:601-606, 2000
4. RUIZ-ORTEGA M, RUPEREZ M, ESTEBAN V, EGIDO J: Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep 5:73-79, 2003
5. JOHNSON RJ, ALPERS CE, YOSHIMURA A, et al: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1994
6. WOLF G, ZIYADEH FN, THAISS F, et al: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the Angiotensin type 2 receptor. J Clin Invest 100:1047-1058, 1997
7. 2 receptors. Am J Pathol 158:1743-1756, 2001
8. RUIZ-ORTEGA M, RUPEREZ M, LORENZO O, et al: Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int 82:12-22, 2002
9. RUPEREZ M, RUIZ-ORTEGA M, ESTEBAN V, et al: Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 163:1937-1947, 2003
10. RUPEREZ M, LORENZO O, BLANCO-COLIO LM, et al: The connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 108:1499-1509, 2003
11. YAMAKAWA T, TANAKA S, NUMAGUCHI K, et al: Involvement of Rhokinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension 35:313-318, 2000
12. MATROUGUI K, TANKO LB, LOUFRANI L, et al: Involvement of Rhokinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries. Arterioscler Thromb Vasc Biol 21:1288-1293, 2001
13. TAKEDA K, ICHIKI T, TOKUNOU T, et al: Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Arterioscler Thromb Vasc Biol 21:868-873, 2001
14. FUNAKOSHI Y, ICHIKI T, SHIMOKAWA H, et al: Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension 38:100-104, 2000
15. AOKI H, IZUMO S, SADOSHIMA J: Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 82:666-676, 1998
16. BAR-SAGI D, HALL A: Ras and Rho GTPases: A family reunion. Cell 103:227-238, 2000
17. KAIBUCHI K, KURODA S, AMANO M: Regulation of cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68:459-486, 1999
18. AMANO M, CHIHARA K, KIMURA K, et al: Formation of actin stress fiber and focal adhesions enhanced by Rho-kinase. Science 275:1308-1311, 1997
19. FUKATA Y, OSHIRO N, KINOSHITA N, et al: Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol 145:347-361, 1999
20. KUREISHI Y, KOBAYASHI S, AMANO M, et al: Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 272:12257-12260, 1997
21. YASUI Y, AMANO M, NAGATA K, et al: Roles of Rho-associated kinase in cytokinesis; mutations in Rho-associated kinase phosphorylation sites impair cytokinetic segregation of glial filaments. J Cell Biol 143:1249-1258, 1998
22. MUKAI Y, SHIMOKAWA H, MATOBA T, et al: Involvement of Rhokinase in hypertensive vascular disease: A novel therapeutic target in hypertension. FASEB J 15:1062-1064, 2001
23. HEUSINGER-RIBEIRO J, EBERLEIN M, WAHAB NA, et al: Expression of connective tissue growth factor in human renal fibroblasts: Regulatory roles of RhoA and cAMP. J Am Soc Nephrol 12:1853-1851, 2001
24. NAGATOYA K, MORIYAMA T, KAWADA N, et al: Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 61:1684-1695, 2002
25. AZNAR S, LACAL JC: Searching new targets for anticancer drug design: The families of Ras and Rho GTPases and their effectors. Prog Nucleic Acid Res Mol Biol 67:193-234, 2001
26. FU M, ZHANG J, ZHU X, et al: Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J Biol Chem 276:45888-45894, 2001
27. ISHIZAKI T, UEHATA M, TAMECHIKA I, et al: Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57: 976-983, 2000
28. RUIZ-ORTEGA M, BUSTOS C, HERNÁNDEZ-PRESA MA, et al: Angiotensin II participates in mononuclear cell recruitment in the kidney through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 gene expression. J Immunol 161:430-439, 1998
29. GUIJARRO C, EGIDO J: Transcription factor κB (NF-κB) in renal disease. Kidney Int 59:415-424, 2001
30. MONTANER S, PERONA R, SANIGER L, LACAL JC: Multiple signalling pathways lead to the activation of the nuclear factor? B by the Rho family of GTPases. J Biol Chem 273:12779-12785, 1998
31. KANDA T, WAKINO S, HAYASHI K, et al: Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int 64:2009-2019, 2003
32. SATOH S, YAMAGUCHI T, HITOMI A, et al: Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. Eur J Pharmacol 455:169-174, 2002
33. TERAISHI K, KURATA H, NAKAJIMA A, et al: Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats. Eur J Pharmacol 505:205-211, 2004
34. NISHIKIMI T, AKIMOTO K, WANG X, et al: Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. Hypertens 22:1787-1796, 2004
35. KATAOKA C, EGASHIRA K, INOUE S, et al: Important role of Rhokinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 39:245-250, 2002
36. PERBAL B: CCN proteins: Multifunctional signalling regulators. Lancet 363:62-64, 2004
37. GUPTA S, CLARKSON MR, DUGGAN J, BRADY HR: Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58:1389-1399, 2000
38. UEHATA M, ISHIZAKI T, SATOH H, et al: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-994, 1997
39. SEKO T, ITO M,KUREISHI Y, et al: Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92:411-418, 2003